Back to Search Start Over

Insmed Announces Pricing of $650 Million Public Offering of Common Stock

Source :
PR Newswire. May 30, 2024
Publication Year :
2024

Abstract

BRIDGEWATER, N.J., May 30, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.795736112